By Phil Newman – Longevity.Technology –
Aubrai debuts on Bio Protocol’s launchpad with a vision to democratize scientific funding and governance.
The persistent challenge facing longevity and regenerative medicine is often not scientific know-how, but rather how innovative projects secure funds to cross the infamous “valley of death” between lab breakthroughs and real-world application. Enter Aubrai, a decentralized science (DeSci) platform that has launched as part of the Bio Protocol on Coinbase’s Layer-2 blockchain, Base. Blending blockchain, artificial intelligence and collective action, Aubrai aims to support a new era of biomedicine research and development.
Longevity.Technology: What sets Aubrai apart is its foundation in thousands of private lab notes, internal chats and unpublished insights from the lab of Dr. Aubrey de Grey and the collective intelligence of the global longevity community. Rather than relying solely on traditional philanthropic or venture capital models, the platform enables token holders to shape research agendas, vote on funding allocations, and potentially share in the rewards of successful discoveries.
